{"entity":{"type":"insider","cik":"0001750094","url":"/insider/0001750094","json_url":"/insider/0001750094.json","name":"Gline Matthew","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":17,"n_filings":15,"first":"2022-03-09","last":"2026-04-20","span_basis":"filed_date"},"name_variants":[{"name":"Gline Matthew","source":"filing","n_filings":15,"first_seen":"2022-03-09","last_seen":"2026-04-20"}],"transactions":[{"id":5802794,"accession":"0001635088-26-000038","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001635088-26-000038","line_url":"/filing/0001635088-26-000038#line-1","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001750094","owner_name":"Gline Matthew","owner_display_name":"Gline Matthew","owner_url":"/insider/0001750094","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":289774.0,"shares_display":"289,774","price_per_share":29.16,"price_display":"29.16","price_state":"stated","total_value":8449809.84,"total_display":"8,449,809.84","total_whole":"8,449,810","shares_owned_after":16736116.0,"shares_owned_after_display":"16,736,116","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-16","filed_date":"2026-04-20","scope":"insider"},{"id":5068732,"accession":"0001140361-25-045906","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001140361-25-045906","line_url":"/filing/0001140361-25-045906","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001750094","owner_name":"Gline Matthew","owner_display_name":"Gline Matthew","owner_url":"/insider/0001750094","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1740000.0,"shares_display":"1,740,000","price_per_share":21.68,"price_display":"21.68","price_state":"stated","total_value":37723200.0,"total_display":"37,723,200.00","total_whole":"37,723,200","shares_owned_after":18616406.0,"shares_owned_after_display":"18,616,406","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-15","filed_date":"2025-12-17","scope":"insider","n_lines":3},{"id":5142556,"accession":"0001140361-25-035435","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-25-035435","line_url":"/filing/0001140361-25-035435#line-1","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001750094","owner_name":"Gline Matthew","owner_display_name":"Gline Matthew","owner_url":"/insider/0001750094","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3315.0,"shares_display":"3,315","price_per_share":15.07,"price_display":"15.07","price_state":"stated","total_value":49957.05,"total_display":"49,957.05","total_whole":"49,957","shares_owned_after":17287081.0,"shares_owned_after_display":"17,287,081","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-18","filed_date":"2025-09-18","scope":"insider"},{"id":2911088,"accession":"0001140361-24-041788","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-24-041788","line_url":"/filing/0001140361-24-041788#line-4","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001750094","owner_name":"Gline Matthew","owner_display_name":"Gline Matthew","owner_url":"/insider/0001750094","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1983257.0,"shares_display":"1,983,257","price_per_share":11.79,"price_display":"11.79","price_state":"stated","total_value":23382600.03,"total_display":"23,382,600.03","total_whole":"23,382,600","shares_owned_after":17870543.0,"shares_owned_after_display":"17,870,543","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-23","filed_date":"2024-09-24","scope":"insider"},{"id":6324757,"accession":"0001140361-22-038695","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-22-038695","line_url":"/filing/0001140361-22-038695#line-1","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001750094","owner_name":"Gline Matthew","owner_display_name":"Gline Matthew","owner_url":"/insider/0001750094","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19276.0,"shares_display":"19,276","price_per_share":4.4,"price_display":"4.40","price_state":"stated","total_value":84814.4,"total_display":"84,814.40","total_whole":"84,814","shares_owned_after":1164009.0,"shares_owned_after_display":"1,164,009","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-25","filed_date":"2022-10-27","scope":"insider"},{"id":6809534,"accession":"0001140361-22-034881","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-22-034881","line_url":"/filing/0001140361-22-034881#line-1","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001750094","owner_name":"Gline Matthew","owner_display_name":"Gline Matthew","owner_url":"/insider/0001750094","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21053.0,"shares_display":"21,053","price_per_share":3.07,"price_display":"3.07","price_state":"stated","total_value":64632.71,"total_display":"64,632.71","total_whole":"64,633","shares_owned_after":1183285.0,"shares_owned_after_display":"1,183,285","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-23","filed_date":"2022-09-27","scope":"insider"},{"id":6645595,"accession":"0000899243-22-029891","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-029891","line_url":"/filing/0000899243-22-029891#line-1","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001750094","owner_name":"Gline Matthew","owner_display_name":"Gline Matthew","owner_url":"/insider/0001750094","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20009.0,"shares_display":"20,009","price_per_share":3.71,"price_display":"3.71","price_state":"stated","total_value":74233.39,"total_display":"74,233.39","total_whole":"74,233","shares_owned_after":1204338.0,"shares_owned_after_display":"1,204,338","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-24","filed_date":"2022-08-26","scope":"insider"},{"id":6944993,"accession":"0000899243-22-026925","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-026925","line_url":"/filing/0000899243-22-026925#line-1","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001750094","owner_name":"Gline Matthew","owner_display_name":"Gline Matthew","owner_url":"/insider/0001750094","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20455.0,"shares_display":"20,455","price_per_share":4.33,"price_display":"4.33","price_state":"stated","total_value":88570.15,"total_display":"88,570.15","total_whole":"88,570","shares_owned_after":1224347.0,"shares_owned_after_display":"1,224,347","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-25","filed_date":"2022-07-27","scope":"insider"},{"id":6443614,"accession":"0000899243-22-024240","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-024240","line_url":"/filing/0000899243-22-024240#line-1","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001750094","owner_name":"Gline Matthew","owner_display_name":"Gline Matthew","owner_url":"/insider/0001750094","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19855.0,"shares_display":"19,855","price_per_share":4.34,"price_display":"4.34","price_state":"stated","total_value":86170.7,"total_display":"86,170.70","total_whole":"86,171","shares_owned_after":1244802.0,"shares_owned_after_display":"1,244,802","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-23","filed_date":"2022-06-27","scope":"insider"},{"id":6620323,"accession":"0000899243-22-019397","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-019397","line_url":"/filing/0000899243-22-019397#line-1","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001750094","owner_name":"Gline Matthew","owner_display_name":"Gline Matthew","owner_url":"/insider/0001750094","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":139791.0,"shares_display":"139,791","price_per_share":3.7,"price_display":"3.70","price_state":"stated","total_value":517226.7,"total_display":"517,226.70","total_whole":"517,227","shares_owned_after":1264657.0,"shares_owned_after_display":"1,264,657","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-20","filed_date":"2022-05-24","scope":"insider"},{"id":6560373,"accession":"0000899243-22-015797","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-015797","line_url":"/filing/0000899243-22-015797#line-1","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001750094","owner_name":"Gline Matthew","owner_display_name":"Gline Matthew","owner_url":"/insider/0001750094","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8509.0,"shares_display":"8,509","price_per_share":3.84,"price_display":"3.84","price_state":"stated","total_value":32674.56,"total_display":"32,674.56","total_whole":"32,675","shares_owned_after":1404448.0,"shares_owned_after_display":"1,404,448","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-25","filed_date":"2022-04-27","scope":"insider"},{"id":6290713,"accession":"0000899243-22-013164","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-013164","line_url":"/filing/0000899243-22-013164#line-2","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001750094","owner_name":"Gline Matthew","owner_display_name":"Gline Matthew","owner_url":"/insider/0001750094","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33686.0,"shares_display":"33,686","price_per_share":4.84,"price_display":"4.84","price_state":"stated","total_value":163040.24,"total_display":"163,040.24","total_whole":"163,040","shares_owned_after":1438211.0,"shares_owned_after_display":"1,438,211","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-30","filed_date":"2022-04-01","scope":"insider"},{"id":6443193,"accession":"0000899243-22-012701","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-012701","line_url":"/filing/0000899243-22-012701#line-1","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001750094","owner_name":"Gline Matthew","owner_display_name":"Gline Matthew","owner_url":"/insider/0001750094","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35386.0,"shares_display":"35,386","price_per_share":5.06,"price_display":"5.06","price_state":"stated","total_value":179053.16,"total_display":"179,053.16","total_whole":"179,053","shares_owned_after":1471897.0,"shares_owned_after_display":"1,471,897","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-25","filed_date":"2022-03-29","scope":"insider"},{"id":6088249,"accession":"0000899243-22-011863","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-011863","line_url":"/filing/0000899243-22-011863#line-1","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001750094","owner_name":"Gline Matthew","owner_display_name":"Gline Matthew","owner_url":"/insider/0001750094","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":82006.0,"shares_display":"82,006","price_per_share":5.13,"price_display":"5.13","price_state":"stated","total_value":420690.78,"total_display":"420,690.78","total_whole":"420,691","shares_owned_after":1507283.0,"shares_owned_after_display":"1,507,283","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-18","filed_date":"2022-03-22","scope":"insider"},{"id":6944246,"accession":"0000899243-22-010363","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-010363","line_url":"/filing/0000899243-22-010363#line-1","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001750094","owner_name":"Gline Matthew","owner_display_name":"Gline Matthew","owner_url":"/insider/0001750094","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":92324.0,"shares_display":"92,324","price_per_share":5.52,"price_display":"5.52","price_state":"stated","total_value":509628.48,"total_display":"509,628.48","total_whole":"509,628","shares_owned_after":1589289.0,"shares_owned_after_display":"1,589,289","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-07","filed_date":"2022-03-09","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":17,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":16,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":17},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001635088","name":"Roivant Sciences Ltd.","url":"/issuer/0001635088","role":"Director, Officer (CEO)","n_filings":15,"first_seen":"2022-03-09","last_seen":"2026-04-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001750094","retrieved_at":"2026-08-25T10:54:45+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}